Beacon Pointe Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $39.1M | Sell |
108,053
-6,391
| -6% | -$2.19M | 0.18% | 120 |
|
|
2026
Q1 | $40.3M | Buy |
114,444
+35,074
| +44% | +$12.5M | 0.21% | 106 |
|
|
2025
Q4 | $26M | Buy |
79,370
+767
| +1% | +$243K | 0.18% | 125 |
|
|
2025
Q3 | $22.2M | Sell |
78,603
-9,378
| -11% | -$2.72M | 0.19% | 119 |
|
|
2025
Q2 | $24.6M | Sell |
87,981
-4,768
| -5% | -$1.35M | 0.26% | 86 |
|
|
2025
Q1 | $28.9M | Buy |
92,749
+547
| +0.6% | +$162K | 0.32% | 68 |
|
|
2024
Q4 | $24M | Sell |
92,202
-33,386
| -27% | -$9.91M | 0.27% | 86 |
|
|
2024
Q3 | $40.5M | Buy |
125,588
+5,910
| +5% | +$1.93M | 0.47% | 44 |
|
|
2024
Q2 | $37.4M | Buy |
119,678
+7,340
| +7% | +$2.16M | 0.44% | 44 |
|
|
2024
Q1 | $31.9M | Sell |
112,338
-4,075
| -4% | -$1.19M | 0.36% | 57 |
|
|
2023
Q4 | $33.5M | Buy |
116,413
+1,312
| +1% | +$357K | 0.4% | 48 |
|
|
2023
Q3 | $30.9M | Buy |
115,101
+21,535
| +23% | +$5.37M | 0.39% | 54 |
|
|
2023
Q2 | $20.8M | Sell |
93,566
-16,335
| -15% | -$3.79M | 0.34% | 66 |
|
|
2023
Q1 | $26.6M | Sell |
109,901
-4,187
| -4% | -$1.03M | 0.45% | 47 |
|
|
2022
Q4 | $30M | Buy |
114,088
+7,099
| +7% | +$1.9M | 0.58% | 39 |
|
|
2022
Q3 | $24.1M | Buy |
106,989
+22
| +0% | +$5.33K | 0.54% | 39 |
|
|
2022
Q2 | $26M | Sell |
106,967
-19,740
| -16% | -$4.84M | 0.55% | 37 |
|
|
2022
Q1 | $30.6M | Buy |
126,707
+45,284
| +56% | +$10.4M | 0.42% | 53 |
|
|
2021
Q4 | $18.3M | Sell |
81,423
-17,943
| -18% | -$3.79M | 0.48% | 47 |
|
|
2021
Q3 | $21.1M | Buy |
99,366
+52,392
| +112% | +$12.1M | 0.52% | 38 |
|
|
2021
Q2 | $11.4M | Buy |
46,974
+32,906
| +234% | +$8.1M | 0.41% | 59 |
|
|
2021
Q1 | $3.5M | Sell |
14,068
-1,188
| -8% | -$283K | 0.21% | 92 |
|
|
2020
Q4 | $3.5M | Buy |
15,256
+5,925
| +63% | +$1.37M | 0.24% | 88 |
|
|
2020
Q3 | $2.37M | Sell |
9,331
-2,950
| -24% | -$731K | 0.23% | 86 |
|
|
2020
Q2 | $2.9M | Buy |
12,281
+6,800
| +124% | +$1.55M | 0.29% | 80 |
|
|
2020
Q1 | $1.11M | Buy |
5,481
+1,335
| +32% | +$292K | 0.18% | 119 |
|
|
2019
Q4 | $1M | Buy |
+4,146
| New | +$914K | 0.31% | 73 |
|
|
2019
Q3 | – | Sell |
-3,866
| Closed | -$713K | – | 173 |
|
|
2019
Q2 | $713K | Buy |
3,866
+26
| +0.7% | +$4.66K | 0.26% | 92 |
|
|
2019
Q1 | $730K | Sell |
3,840
-31
| -0.8% | -$5.92K | 0.27% | 89 |
|
|
2018
Q4 | $754K | Buy |
+3,871
| New | +$755K | 0.46% | 61 |
|
Other funds holding AMGN
Beacon Pointe Advisors's AMGN Position: Q2 2026 in Review
Beacon Pointe Advisors reduced its Amgen (AMGN) stake by 5.6% in Q2 2026, selling an estimated $2.19M and leaving 108,053 shares worth $39.1M. The position accounts for 0.18% of the portfolio, ranked #120.
Beacon Pointe Advisors first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. The position peaked at $40.5M in Q3 2024. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Beacon Pointe Advisors held 108,053 shares of Amgen worth $39.1M as of Q2 2026.
- Beacon Pointe Advisors sold 6,391 Amgen shares in Q2 2026, an estimated $2.19M.
- Amgen made up 0.18% of Beacon Pointe Advisors's portfolio in Q2 2026, its #120 holding.
- Beacon Pointe Advisors first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
- Beacon Pointe Advisors's Amgen position peaked at $40.5M in Q3 2024.
- 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.